Peter Wikstroem

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 95(Granted Patents)

Location History:

Oberwil, CH (1996 - 1997)
Gipf-Oberfrick, CH (2002 - 2017)
Basel, CH (2018)
Kaiseraugst, CH (2018 - 2019)

Company Filing History:

Years Active: 1996-2019

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10179797 - Phosphinic peptide derivatives for use as MMP-12 inhibitors (2019-01-15),

2. 10059738 - Process for the production of a dipeptide derivative (2018-08-28),

3. 9980889 - Compositions comprising P-hydroxybenzylamine (2018-05-29),

4. RE46424 - Method for producing 3-amidinophenylalanine derivatives (2017-06-05),

5. 8642761 - Method for producing 3-amidinophenylalanine derivatives (2014-02-04),

6. 8088921 - Method for producing 3-amidinophenylalanine derivatives (2012-01-03),

7. 7964630 - Topical application agents against mimic and age-related wrinkles (2011-06-21),

8. 7884206 - Method for producing 3-amidinophenylalanine derivatives (2011-02-08),

9. 7718406 - Substrates for TAFI (A) (2010-05-18),

10. 7211670 - Method for producing 3-amidinophenylalanine derivatives (2007-05-01),

11. 6495336 - Oligopeptide derivatives for the electrochemical measurement of protease activity (2002-12-17),

12. 5607937 - Piperazides of substituted phenylalanine derivatives as thrombin (1997-03-04),

13. 5518735 - Meta-substituted phenylalanine derivatives (1996-05-21),

Title: Peter Wikstroem: Innovator in Peptide Derivatives

Introduction

Peter Wikstroem is a notable inventor based in Gipf-Oberfrick, Switzerland. He has made significant contributions to the field of peptide derivatives, holding a total of 13 patents. His work focuses on developing innovative compounds that have applications in both cosmetic and pharmaceutical industries.

Latest Patents

Among his latest patents is the invention of phosphinic peptide derivatives for use as MMP-12 inhibitors. This invention relates to compounds that selectively inhibit Matrix Metalloprotease-12 (MMP-12), which is crucial for the prevention and treatment of ailments associated with this enzyme. Another significant patent involves a process for the production of a dipeptide derivative, which describes a novel and improved method for manufacturing specific compounds, including benzylsulfonyl-Ser-X-4-amidinobenzylamide.

Career Highlights

Throughout his career, Peter has worked with various companies, including Wilex AG and DSM IP Assets B.V. His expertise in peptide chemistry has positioned him as a valuable asset in the research and development sectors of these organizations.

Collaborations

Peter has collaborated with notable professionals in his field, including Hugo Ziegler and Helmut Vieweg. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Peter Wikstroem's contributions to the field of peptide derivatives demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of biochemical processes and their applications in real-world scenarios.

This text is generated by artificial intelligence and may not be accurate.